I Inoue

676 total citations
13 papers, 537 citations indexed

About

I Inoue is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, I Inoue has authored 13 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Nephrology. Recurrent topics in I Inoue's work include Cancer, Hypoxia, and Metabolism (2 papers), Plant Pathogens and Fungal Diseases (2 papers) and Photodynamic Therapy Research Studies (1 paper). I Inoue is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Plant Pathogens and Fungal Diseases (2 papers) and Photodynamic Therapy Research Studies (1 paper). I Inoue collaborates with scholars based in Japan and Ireland. I Inoue's co-authors include Fumio Namiki, Takashi Tsuge, Mitsuru Okuda, Yoshikatsu Fujita, Kazufumi Nishi, Junji Yoshida, Hisao Seo, Hitoshi Kunoh, Toshiaki Ohara and Takuya Koshizaka and has published in prestigious journals such as The Plant Cell, Genetics and Molecular Plant-Microbe Interactions.

In The Last Decade

I Inoue

12 papers receiving 522 citations

Peers

I Inoue
Comparison fields: 5 of 57
  • Plant Science 317
  • Molecular Biology 240
  • Cell Biology 223
  • Pharmacology 87
  • Immunology 53
Replace Kyuyong Han with:
Kyuyong Han South Korea
Naoko Norioka Japan
Srirama M. Bhairi United States
Marc J. Curtis United States
Ronit Weisman Israel
Adriana Cabral Netherlands
Susanne Reinold Austria
Teresa L. Shock United States
Rebeca D. Martínez-Contreras Mexico
Maria Palmieri Italy
Kyuyong Han South Korea View profile →
Citations per field, relative to I Inoue
I Inoue · 1×
Citations per year, relative to I Inoue
I Inoue · 1×

Countries citing papers authored by I Inoue

Since Specialization
Citations

This map shows the geographic impact of I Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Inoue more than expected).

Fields of papers citing papers by I Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Inoue. The network helps show where I Inoue may publish in the future.

Co-authorship network of co-authors of I Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of I Inoue. A scholar is included among the top collaborators of I Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Inoue. I Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Work Indexed citations
1 60
2 101
3 228
4
Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.
13
5
A new treatment strategy using both intermittent short dialysis and continuous ambulatory hemofiltration.
1
6
Change in sympathetic activity before, during, and after dialysis-induced hypotension.
7
7
Determination of the molecular nature and cellular localization of Thy-1 in human renal tissue.
15
8
Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody.
84
9
[Basic studies on chemotherapy of brain tumors by means of liposomes: affinity of sulfatide-inserted liposomes to human glioma cells].
3
10
[A phase II study of UFT in non-small cell lung cancer].
10
11
[Combination therapy with HU IFN-beta and ACNU against malignant brain tumors, Part 1. Experimental study in vitro].
6
12
[MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
3
13
[Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026